CNTG Centogene NV Gross Profit Margin

Centogene N.V. diagnostic efficiency is based on the scale of its biobank and partnerships with pharma behemoths, while cash flow stability relies on the volume of research contracts. The current gross margin demonstrates operational efficiency, where the value of 0.00 corresponds to the current metric. Independence from macroeconomics and the demand for innovation make this sector a reliable defensive asset.
Financial and market metric breakdowns for CENTOGENE (CNTG)

The long-term sustainability of Centogene N.V. (CNTG) is determined by the efficiency of managing direct diagnostic costs. Gross margin measures the profit share of each unit of revenue after deducting production expenses, reflecting the fundamental profitability of operations. An analysis of the gross margin after cost of goods sold demonstrates how sequencing robotics and AI analysis reduce the impact of human error, optimizing test costs and strengthening the business model.